1-181724499-G-C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_001205293.3(CACNA1E):c.2104G>C(p.Ala702Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A702V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001205293.3 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 69Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001205293.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1E | NM_001205293.3 | MANE Select | c.2104G>C | p.Ala702Pro | missense | Exon 17 of 48 | NP_001192222.1 | ||
| CACNA1E | NM_000721.4 | c.2104G>C | p.Ala702Pro | missense | Exon 17 of 47 | NP_000712.2 | |||
| CACNA1E | NM_001205294.2 | c.2104G>C | p.Ala702Pro | missense | Exon 17 of 46 | NP_001192223.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1E | ENST00000367573.7 | TSL:1 MANE Select | c.2104G>C | p.Ala702Pro | missense | Exon 17 of 48 | ENSP00000356545.2 | ||
| CACNA1E | ENST00000360108.7 | TSL:5 | c.2104G>C | p.Ala702Pro | missense | Exon 17 of 47 | ENSP00000353222.3 | ||
| CACNA1E | ENST00000367570.6 | TSL:1 | c.2104G>C | p.Ala702Pro | missense | Exon 17 of 47 | ENSP00000356542.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The A702P variantl has not been published as pathogenic, nor has it been reported as a benign variant to our knowledge.The A702P variant was not observed in approximately 6200 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. It is a semi-conservative amino acid substitution that occurs at a conserved position within the transmembrane segment S6 of the second homologous domain. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, the A702P variant is likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at